Study shows lasting benefits of anti-hormonal therapy in postmenopausal women

[News]

Today, women with estrogen-sensitive breast cancer receive anti-hormonal therapy. Researchers now show that postmenopausal women with low-risk tumors have a long-term benefit for at least 20 years, while the benefit was more short-term for younger women with similar tumor characteristics who had not yet gone through the menopause.

More... (https://www.news-medical.net/news/20241203/Study-shows-lasting-benefits-of-anti-hormonal-therapy-in-postmenopausal-women.aspx)